GENEURO SA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.43 EUR | 0.00% |
|
0.00% | +31.19% |
| 03-20 | Geneuro SA Announces Appointments of Board of Directors | CI |
| 02-02 | GeNeuro: share price falls after private placement | CF |
Chart calendar GeNeuro SA
1f6f7ecfdb3d221e96c4b52fe3.WSgFe1ew-8TxdyPV3cSbbIAjxzECDHOaDWhpvvTIlxg.LGc3MwWAz5zAEUm-6q_hW_kT8GVrPhDDVF4oyba54kthe3ZMY_yQtqAwUA~6f2e3ae7cc85dbbf0fa2e9df326b662e
Upcoming events on GeNeuro SA
Past events on GeNeuro SA
| Today | Q1 2024 Earnings Release (Projected) |
| 03/04/2024 | Investor Access Event |
| 01/04/2024 | Q4 2023 Earnings Release (Projected) |
| 27/03/2024 | Smallcap Event |
| 17/03/2024 | Extraordinary Shareholders Meeting |
| 08/10/2023 | Investor Access Event |
| 03/10/2023 | Bio Future Conference |
| 02/10/2023 06:30 | Q2 2023 Earnings Release |
| 14/06/2023 14:00 | Annual General Meeting |
| 04/06/2023 | BIO International Convention |
| 24/05/2023 | Gilbert Dupont Midcaps Forum |
| 02/05/2023 | LSX World Congress |
| 05/04/2023 06:30 | Q4 2022 Earnings Release |
| 10/10/2022 | International Society of Neuro Virology Symposium |
| 05/10/2022 | Investor Meeting |
| 29/09/2022 17:30 | Interim 2022 Earnings Release |
| 27/09/2022 | Lyon Pole Bourse Conference |
| 20/09/2022 | Sachs Associates Biotech in Europe Forum |
| 27/06/2022 | Gilbert Dupont Midcaps Forum |
| 12/06/2022 | BIO International Convention |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 7,46 24,0 -68.9% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million EUR | Released Forecast Spread | -8,02 -0,60 -1236.65% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | -11,3 |
|
EBIT Million EUR | Released Forecast Spread | -8,09 -0,60 -1248.1% | -8,99 -24,4 63.14% | -7,46 -11,0 32.24% | -6,37 -14,1 54.69% | -11,2 -7,15 -57% | -11,3 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -8,33 -0,60 -1287.97% | -9,46 -14,1 32.9% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
Net income Million EUR | Released Forecast Spread | -8,33 -0,60 -1287.97% | -9,46 -24,5 61.46% | -8,96 -11,3 20.45% | -6,82 -14,4 52.56% | -12,2 -7,28 -67.67% | -11,3 |
|
EPS EUR | Released Forecast Spread | -0,57 -0,04 -1325% | -0,65 -0,96 32.39% | -0,45 -0,62 27.8% | -0,32 -0,28 -12.58% | -0,51 -0,29 -75.22% | -0,43 |
| Announcement Date | 01/04/19 | 07/04/20 | 06/04/21 | 04/04/22 | 05/04/23 | - |
Quarterly results
| Fiscal Period | December | 2021 S1 |
|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 0,00 |
|
Net income Million EUR | Released Forecast Spread | -3,40 |
|
EPS EUR | Released Forecast Spread | -0,17 |
| Announcement Date | 29/09/21 |
| Today 21:05 | QIAGEN N.V.: Q1 2024 Earnings Release |
| 29/04/2024 | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
| 01/05/2024 11:30 | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| 01/05/2024 11:30 | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| 01/05/2024 12:00 | ALKERMES PLC: Q1 2024 Earnings Release |
| 01/05/2024 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
Past sector events for GeNeuro SA
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- GNRO Stock
- Calendar GeNeuro SA
